About
Gamida Cell develops allogeneic cell therapy products using proprietary nicotinamide (NAM) technology to treat malignant and non-malignant hematological conditions.
Explore Gamida Cell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.